BioGaia AB ser. B (0GTN)

93.02
-422.48(-81.96%)
  • Volume:
    15,477
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    93.02 - 93.02

0GTN Overview

Prev. Close
515.5
Day's Range
93.02-93.02
Revenue
491.22M
Open
101.19
52 wk Range
90.6-113.16
EPS
2.44
Volume
15,477
Market Cap
9.35B
Dividend (Yield)
3.63
(0.79%)
Average Volume (3m)
3,803
P/E Ratio
39.24
Beta
0.595
1-Year Change
-
Shares Outstanding
100,982,310
Next Earnings Date
20 Oct 2022
What is your sentiment on BioGaia B?
or
Market is currently closed. Voting is open during market hours.

BioGaia AB ser. B Company Profile

BioGaia AB ser. B Company Profile

Employees
189
Market
Sweden

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellNeutralSellSell
Technical IndicatorsStrong BuyStrong BuyBuySellBuy
SummaryNeutralNeutralNeutralSellNeutral